- Home
- BIOA vs DMO Comparison
BIOA vs DMO Comparison
Compare BIOA & DMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BIOA
- DMO
- Stock Information
- Founded
- BIOA 2015
- DMO 2009
- Country
- BIOA United States
- DMO United States
- Employees
- BIOA 64
- DMO N/A
- Industry
- BIOA Biotechnology: Pharmaceutical Preparations
- DMO Trusts Except Educational Religious and Charitable
- Sector
- BIOA Health Care
- DMO Finance
- Exchange
- BIOA Nasdaq
- DMO Nasdaq
- Market Cap
- BIOA 175.7M
- DMO 135.9M
- IPO Year
- BIOA 2024
- DMO N/A
- Fundamental
- Price
- BIOA $5.00
- DMO $12.00
- Analyst Decision
- BIOA Hold
- DMO
- Analyst Count
- BIOA 4
- DMO 0
- Target Price
- BIOA $5.67
- DMO N/A
- AVG Volume (30 Days)
- BIOA 180.2K
- DMO 49.6K
- Earning Date
- BIOA 11-06-2025
- DMO 01-01-0001
- Dividend Yield
- BIOA N/A
- DMO 12.06%
- EPS Growth
- BIOA N/A
- DMO N/A
- EPS
- BIOA N/A
- DMO N/A
- Revenue
- BIOA $3,863,000.00
- DMO N/A
- Revenue This Year
- BIOA N/A
- DMO N/A
- Revenue Next Year
- BIOA N/A
- DMO N/A
- P/E Ratio
- BIOA N/A
- DMO N/A
- Revenue Growth
- BIOA N/A
- DMO N/A
- 52 Week Low
- BIOA $2.88
- DMO $10.00
- 52 Week High
- BIOA $26.62
- DMO $11.80
- Technical
- Relative Strength Index (RSI)
- BIOA 59.80
- DMO 61.82
- Support Level
- BIOA $4.68
- DMO $11.89
- Resistance Level
- BIOA $5.09
- DMO $11.98
- Average True Range (ATR)
- BIOA 0.24
- DMO 0.06
- MACD
- BIOA 0.01
- DMO 0.01
- Stochastic Oscillator
- BIOA 80.36
- DMO 97.37
About BIOA BioAge Labs Inc. Common Stock
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.
About DMO Western Asset Mortgage Opportunity Fund Inc.
Western Asset Mortgage Defined Opportunity Fund Inc is a non-diversified, limited-term, closed-end management investment company. The fund's primary investment objective is to provide current income. As a secondary investment objective, the Fund will seek capital appreciation. The Fund seeks to achieve its investment objectives by investing in a diverse portfolio of mortgage-backed securities, consisting of non-agency residential mortgage-backed securities and commercial mortgage-backed securities.